EUDA Health Holdings Ltd (EUDAW) Financial Ratio Screen

NASDAQ Singapore N/A
INSUFFICIENT / NOT IMPLEMENTED*
Automated financial screen · activity assessed separately
EUDA Health Holdings Ltd (EUDAW) needs additional financial data before the automated screen can be completed. One or more financial fields are missing; this is not a negative screening result.

Track EUDAW screening changes

Get an email when this stock's published screening status or underlying ratios change.

MSCI new-inclusion financial-ratio snapshot

EUDAW financial screening at a glance

INSUFFICIENT / NOT IMPLEMENTED*Financial ratios shown separately from business review — not a fatwa
Debt ratio
75.0%
Fail vs 30%
Cash ratio
14.0%
Pass vs 30%
Receivables + cash
24.0%
Pass vs 30%
Impermissible income
N/A
Not available vs 5%

Calculation date: 2026-08-31. Financial period used: December 2024. The ratios are automated proxies inspired by published methodologies; they are not official index determinations.

Independent method comparison

What the available screens say

How MSCI, FTSE and S&P-style screens differ
Request this stock review
MSCI-styleMore financial data neededNo negative conclusion follows from missing data
FTSE/Yasaar-styleMore financial data neededNo negative conclusion follows from missing data
S&P-style provisionalNot yet availableRequired denominator or financial data is incomplete
Business activityAssessment pendingFinancial results do not determine business permissibility
Complete screening result: not yet completeA complete result requires both supported financial criteria and adequate activity evidence. This site does not issue a fatwa or official index decision.
Financial periodDecember 2024Calculation date2026-08-31S&P-style historynot availableLast activity reviewnot yet reviewed

The request button opens your email application with a pre-filled message. HalalStockGuide receives no address or request unless you choose to send it.

Business activity evidence

Activity assessment in progress

The supplied classification (not available) is only a starting point. Revenue evidence is being assessed before any complete screening conclusion.

Revenue segments: Not yet checked against an SEC annual filing.

Profile description reviewed: EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.

Sources to verify: Secondary company profile and classification · Issuer website · SEC issuer filings

A sector label or company description can flag a risk but cannot establish a compliant-revenue percentage. Only sourced segment disclosures may support that calculation.

Published-ratio reproductions (not certifications)

The table shows implemented MSCI and FTSE/Yasaar-style asset-based models plus a provisional S&P-style leverage reconstruction where a complete 36-month denominator exists. These are independent calculations, not official index results or Shariah determinations. See formulas, sources and limitations.

Based on financial data from December 2024

Standard Debt Ratio Cash Ratio Receivables Income Status
MSCI 75.0%
/ 30%
14.0%
/ 30%
24.0%
/ 30%
N/A INSUFFICIENT / NOT IMPLEMENTED*
FTSE 75.0%
/ 33%
14.0%
/ 33%
24.0%
/ 50%
N/A INSUFFICIENT / NOT IMPLEMENTED*

Financial Highlights

P/B Ratio
-0.0
Revenue
$4M
Growth: 60.2%
Beta
-0.1
Low volatility
Current Ratio
0.2

Profitability

Gross Margin 22.4%
Operating Margin -37.0%
Net Margin 5.2%
Return on Assets (ROA) -63.9%

Cash Flow & Balance Sheet

Operating Cash Flow-$2M
Free Cash Flow-$2M
Total Debt$1M
Current Ratio0.2
Total Assets$2M

Price & Trading

Last Close$0.03
Beta-0.1
52-Week Range
$0.02
$0.03

Financial data provenance and verification

The displayed fields were imported from yfinance on 2026-03-29 for the financial period December 2024. This is a secondary data feed and can differ from amended or newly filed statements.

Verification rule: check debt, cash, receivables, revenue and interest income against the latest primary filing before relying on an automated ratio.

About EUDA Health Holdings Ltd (EUDAW)

CEO
Mr. Alfred Lim
Employees
117
Country
Singapore
Exchange
NASDAQ
Currency
USD

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy capsule, stem cell therapy, and CRISPR gene editing treatment services; and supplements. The company also provides property management services. The company is headquartered in Singapore.

Popular halal stock checks

Explore other frequently viewed automated stock screens and compare the available financial ratios.

Frequently Asked Questions

Is EUDA Health Holdings Ltd (EUDAW) halal to invest in?

The current automated result is More financial data is needed. It uses available public financial fields and simplified methodology proxies. It is not a fatwa or an official determination by AAOIFI, DJIM, MSCI, S&P, or FTSE.

What is EUDA Health Holdings Ltd's debt ratio?

EUDA Health Holdings Ltd's debt ratio is 75.0% in the MSCI new-inclusion reproduction: total debt divided by total assets, against a 30% threshold. See the methodology page for the official source and limitations.

What are EUDA Health Holdings Ltd's key financial metrics?

EUDA Health Holdings Ltd has a market capitalization of N/A in its listing currency, and revenue of $4M. The company maintains a gross margin of 22.4% and a net margin of 5.2%.

How often is the screening data updated?

Calculation date: 2026-08-31. Financial period: December 2024. These dates are shown separately because regenerating this page does not refresh the underlying data.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.